Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1962 1
1963 1
1965 1
1966 2
1967 2
1968 4
1969 1
1970 1
1972 1
1973 1
1974 5
1975 6
1976 5
1977 2
1978 3
1979 1
1981 5
1982 2
1983 3
1984 10
1985 15
1986 19
1987 23
1988 13
1989 24
1990 19
1991 30
1992 14
1993 15
1994 10
1995 25
1996 14
1997 25
1998 19
1999 14
2000 20
2001 19
2002 29
2003 40
2004 45
2005 42
2006 60
2007 74
2008 78
2009 125
2010 115
2011 131
2012 119
2013 122
2014 156
2015 138
2016 171
2017 150
2018 121
2019 147
2020 213
2021 210
2022 200
2023 197
2024 83

Text availability

Article attribute

Article type

Publication date

Search Results

2,839 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O, Luft A, Akopov A, Martinez-Marti A, Kenmotsu H, Chen YM, Chella A, Sugawara S, Voong D, Wu F, Yi J, Deng Y, McCleland M, Bennett E, Gitlitz B, Wakelee H; IMpower010 Investigators. Felip E, et al. Among authors: chen ym. Lancet. 2021 Oct 9;398(10308):1344-1357. doi: 10.1016/S0140-6736(21)02098-5. Epub 2021 Sep 20. Lancet. 2021. PMID: 34555333 Clinical Trial.
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC, Liang Y, Yarmishyn AA, Hsiao YJ, Lin TY, Lin TW, Teng YC, Yang YP, Wang ML, Chien CS, Luo YH, Chen YM, Hsu PK, Chiou SH, Chien Y. Teng PC, et al. Among authors: chen ym. Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592. Int J Mol Sci. 2021. PMID: 34638933 Free PMC article. Review.
Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility.
Xu F, Yu EY, Cai X, Yue L, Jing LP, Liang X, Fu Y, Miao Z, Yang M, Shuai M, Gou W, Xiao C, Xue Z, Xie Y, Li S, Lu S, Shi M, Wang X, Hu W, Langenberg C, Yang J, Chen YM, Guo T, Zheng JS. Xu F, et al. Among authors: chen ym. Nat Commun. 2023 Feb 16;14(1):896. doi: 10.1038/s41467-023-36491-3. Nat Commun. 2023. PMID: 36797296 Free PMC article.
Gut butyrate-producers confer post-infarction cardiac protection.
Chen HC, Liu YW, Chang KC, Wu YW, Chen YM, Chao YK, You MY, Lundy DJ, Lin CJ, Hsieh ML, Cheng YC, Prajnamitra RP, Lin PJ, Ruan SC, Chen DH, Shih ESC, Chen KW, Chang SS, Chang CMC, Puntney R, Moy AW, Cheng YY, Chien HY, Lee JJ, Wu DC, Hwang MJ, Coonen J, Hacker TA, Yen CE, Rey FE, Kamp TJ, Hsieh PCH. Chen HC, et al. Among authors: chen ym. Nat Commun. 2023 Nov 9;14(1):7249. doi: 10.1038/s41467-023-43167-5. Nat Commun. 2023. PMID: 37945565 Free PMC article.
2,839 results